How to Combine Patient-Reported Outcomes in a Single Endpoint: A Practical Guide for Clinical Trials

Patient-reported outcomes (PROs) have become increasingly important in clinical research because they provide direct insight into how patients feel and function during treatment. Fatigue, pain, physical functioning, emotional wellbeing, symptom burden, and health-related quality of life are now routinely measured alongside traditional clinical endpoints.

As the number of patient-reported outcomes included in clinical trials continues to grow, researchers face an import ant methodological challenge: how can multiple patient-reported outcomes be combined into a single endpoint?

The question matters because evaluating each PRO separately can create a fragmented picture of treatment benefit. A new therapy might improve fatigue but have little impact on physical functioning. It might reduce pain while causing side effects that negatively impact quality of life. When each outcome is analyzed independently, it can become difficult to determine whether patients are truly better off overall.

Why combine patient-reported outcomes?

Clinical decision-making rarely depends on a single aspect of a patient’s experience. Patients generally care about several outcomes simultaneously. In oncology, for example, a patient may value symptom relief, preserved daily functioning, and improved quality of life. In rare diseases, reducing disease burden while maintaining treatment convenience may be equally important.

Combining multiple patient-reported outcomes into a single endpoint can provide a more holistic view of treatment benefit. It can simplify interpretation, reduce the need for multiple analyses, and better reflect the multidimensional nature of patient wellbeing.

However, combining PROs is not straightforward. Different outcomes often have different levels of importance, different scales, and different levels of clinical relevance.

Traditional approaches to creating a patient-reported outcome endpoint

One common approach is to aggregate multiple questionnaire items into a summary score. Many validated instruments already generate domain scores or global quality-of-life scores by combining responses across several questions.

Another approach is to analyze multiple PROs as co-primary endpoints. While scientifically valid, this can make interpretation challenging when some outcomes show improvement and others do not.

Researchers also frequently use responder analyses, defining success as achieving a predefined level of improvement across one or more outcomes. Although easy to communicate, responder analyses often reduce rich continuous information into a simple yes-or-no classification.

These methods can be useful, but they do not always reflect the real-world trade-offs patients make. Not all outcomes are equally important, and treatment decisions often involve balancing benefits against drawbacks rather than maximizing a single score.

The challenge of composite patient-reported outcome endpoints

Traditional composite endpoints generally require researchers to combine outcomes through mathematical formulas or predefined weightings. This can introduce assumptions about the relative importance of different outcomes.

For example, should a one-point improvement in fatigue have the same value as a one-point improvement in pain? Should physical functioning carry more weight than emotional wellbeing? Should overall quality of life be considered more important than treatment convenience?

There is no universally accepted answer to these questions.

As a result, many composite approaches risk oversimplifying the patient experience or masking clinically meaningful differences between treatment groups.

A patient-centered alternative: Generalized Pairwise Comparisons (GPC)

Generalized Pairwise Comparisons (GPC) offers a different way to combine multiple patient-reported outcomes into a single endpoint.

Instead of merging outcomes into a weighted score, GPC compares patients receiving treatment with patients receiving control according to a clinically meaningful hierarchy of prioritized outcomes.

Researchers can define the order of importance based on clinical expertise, patient input, regulatory expectations, or study objectives. For example, severe symptom reduction may be considered first, followed by physical functioning, fatigue, and overall quality of life.

Each treated patient is compared with each control patient. If one outcome clearly distinguishes the two patients, the comparison is resolved. If not, the analysis moves to the next outcome in the hierarchy.

This process allows multiple patient-reported outcomes to contribute to a single overall assessment without requiring arbitrary weighting systems.

How Net Treatment Benefit summarizes multiple PROs

The result of a Generalized Pairwise Comparison analysis is typically expressed as the Net Treatment Benefit (NTB).

NTB summarizes the difference between favorable and unfavorable comparisons across all patient pairs. In simple terms, it estimates whether patients receiving the treatment are more likely to experience a better overall outcome than patients receiving the comparator.

Because GPC evaluates outcomes according to predefined clinical priorities, NTB captures treatment benefit in a way that aligns more closely with how clinicians and patients evaluate therapies in practice.

Rather than asking whether treatment improves a single PRO score, the analysis asks a more meaningful question: Which treatment gives patients the better overall experience when all important outcomes are considered together?

Can patient-reported outcomes and clinical outcomes be combined?

One of the major advantages of GPC is that patient-reported outcomes do not need to be analyzed separately from traditional clinical endpoints. Researchers can evaluate efficacy, safety, symptoms, functioning, and quality of life within the same framework.

For example, a study could prioritize overall survival first, followed by severe adverse events, followed by fatigue, pain, and health-related quality of life.

This approach allows treatment benefit and patient experience to be assessed together rather than in isolation.

Choosing the right method to combine patient-reported outcomes

There is no single approach that works for every study. Summary scores, composite endpoints, co-primary endpoints, and responder analyses all have a role in clinical research.

However, when studies collect multiple patient-reported outcomes and seek a single interpretable measure of overall benefit, methods such as Generalized Pairwise Comparisons and Net Treatment Benefit can offer important advantages. They preserve patient-level information, respect clinical priorities, avoid arbitrary weighting assumptions, and generate a single endpoint that reflects what matters most to patients.

As regulators, HTA bodies, clinicians, and patient advocates continue to emphasize patient-centered evidence, approaches that combine multiple patient-reported outcomes into a meaningful overall assessment are becoming increasingly valuable.

Frequently Asked Questions